Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (2 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (2)
Type
(
1 selected
)
Type
Guidance (752)
Guidance programme
(
1 selected
)
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (224)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (17)
Highly specialised technologies guidance (27)
Interventional procedures guidance (598)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (340)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (752)
Apply filters
Showing 101 to 150 of 752
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Teclistamab for treating relapsed or refractory multiple myeloma after 3 or more therapies (terminated appraisal)
TA869
16 February 2023
16 February 2023
Vutrisiran for treating hereditary transthyretin-related amyloidosis
TA868
15 February 2023
15 February 2023
Nivolumab with fluoropyrimidine- and platinum-based chemotherapy for untreated unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinoma
TA865
8 February 2023
8 February 2023
Regorafenib for previously treated metastatic colorectal cancer
TA866
8 February 2023
8 February 2023
Upadacitinib for treating active non-radiographic axial spondyloarthritis
TA861
1 February 2023
1 February 2023
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 treatments
TA862
1 February 2023
1 February 2023
Somatrogon for treating growth disturbance in children and young people aged 3 years and over
TA863
1 February 2023
1 February 2023
Nintedanib for treating idiopathic pulmonary fibrosis when forced vital capacity is above 80% predicted
TA864
1 February 2023
1 February 2023
Maribavir for treating refractory cytomegalovirus infection after transplant
TA860
18 January 2023
18 January 2023
Angiotensin II for treating vasosuppressor-resistant hypotension caused by septic or distributive shock (terminated appraisal)
TA859
16 January 2023
16 January 2023
Nivolumab with platinum- and fluoropyrimidine-based chemotherapy for untreated HER2-negative advanced gastric, gastro-oesophageal junction or oesophageal adenocarcinoma
TA857
11 January 2023
11 January 2023
Lenvatinib with pembrolizumab for untreated advanced renal cell carcinoma
TA858
11 January 2023
11 January 2023
Upadacitinib for treating moderately to severely active ulcerative colitis
TA856
4 January 2023
4 January 2023
Avatrombopag for treating primary chronic immune thrombocytopenia
TA853
15 December 2022
15 December 2022
Cabozantinib for previously treated advanced hepatocellular carcinoma
TA849
14 December 2022
14 December 2022
Amivantamab for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapy
TA850
14 December 2022
14 December 2022
Pembrolizumab for neoadjuvant and adjuvant treatment of triple-negative early or locally advanced breast cancer
TA851
14 December 2022
14 December 2022
Trifluridine–tipiracil for treating metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma after 2 or more treatments
TA852
14 December 2022
14 December 2022
Esketamine nasal spray for treatment-resistant depression
TA854
14 December 2022
14 December 2022
Cemiplimab for untreated PD-L1-positive advanced or metastatic non-small-cell lung cancer (terminated appraisal)
TA848
1 December 2022
1 December 2022
Mepolizumab for treating eosinophilic granulomatosis with polyangiitis (terminated appraisal)
TA845
29 November 2022
29 November 2022
Mepolizumab for treating severe hypereosinophilic syndrome (terminated appraisal)
TA846
29 November 2022
29 November 2022
Mepolizumab for treating severe chronic rhinosinusitis with nasal polyps (terminated appraisal)
TA847
29 November 2022
29 November 2022
Luspatercept for treating anaemia caused by myelodysplastic syndromes (terminated appraisal)
TA844
24 November 2022
24 November 2022
Luspatercept for treating anaemia caused by beta-thalassaemia (terminated appraisal)
TA843
24 November 2022
24 November 2022
Carfilzomib with daratumumab and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)
TA841
22 November 2022
22 November 2022
Tisagenlecleucel for treating follicular lymphoma after 2 or more therapies (terminated appraisal)
TA842
22 November 2022
22 November 2022
Ruxolitinib for treating acute graft versus host disease refractory to corticosteroids (terminated appraisal)
TA839
16 November 2022
16 November 2022
Ruxolitinib for treating chronic graft versus host disease refractory to corticosteroids (terminated appraisal)
TA840
16 November 2022
16 November 2022
Slow-release potassium bicarbonate–potassium citrate for treating distal renal tubular acidosis (terminated appraisal)
TA838
2 November 2022
2 November 2022
Pembrolizumab for adjuvant treatment of resected stage 2B or 2C melanoma
TA837
26 October 2022
26 October 2022
Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy
TA836
26 October 2022
26 October 2022
Pembrolizumab for adjuvant treatment of renal cell carcinoma
TA830
19 October 2022
19 October 2022
Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids
TA832
19 October 2022
19 October 2022
Zanubrutinib for treating Waldenstrom's macroglobulinaemia
TA833
19 October 2022
19 October 2022
Fostamatinib for treating refractory chronic immune thrombocytopenia
TA835
19 October 2022
19 October 2022
SQ HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (terminated appraisal)
TA834
12 October 2022
12 October 2022
Oral azacitidine for maintenance treatment of acute myeloid leukaemia after induction therapy
TA827
5 October 2022
5 October 2022
Ozanimod for treating moderately to severely active ulcerative colitis
TA828
5 October 2022
5 October 2022
Upadacitinib for treating active ankylosing spondylitis
TA829
30 September 2022
30 September 2022
Atezolizumab for adjuvant treatment of resected non-small-cell lung cancer
TA823
28 September 2022
28 September 2022
Avacopan for treating severe active granulomatosis with polyangiitis or microscopic polyangiitis
TA825
21 September 2022
21 September 2022
Vedolizumab for treating chronic refractory pouchitis after surgery for ulcerative colitis (terminated appraisal)
TA826
21 September 2022
21 September 2022
Melphalan for haematological diseases before allogeneic haematopoietic stem cell transplant (terminated appraisal)
TA822
14 September 2022
14 September 2022
Dexamethasone intravitreal implant for treating diabetic macular oedema
TA824
14 September 2022
14 September 2022
Brolucizumab for treating diabetic macular oedema
TA820
31 August 2022
31 August 2022
Avalglucosidase alfa for treating Pompe disease
TA821
24 August 2022
24 August 2022
Sacituzumab govitecan for treating unresectable triple-negative advanced breast cancer after 2 or more therapies
TA819
17 August 2022
17 August 2022
Nivolumab with ipilimumab for untreated unresectable malignant pleural mesothelioma
TA818
17 August 2022
17 August 2022
Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs
TA815
10 August 2022
10 August 2022
Previous page
1
2
Current page
3
4
5
…
16
Page
3
of
16
Next page
Results per page
10
25
50
All
Back to top